Organization Profile

You just read:

Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers

News provided by

Lorus Therapeutics Inc.

Jul 28, 2014, 07:00 ET